Random Pick of The Week | $AKBA BioTech
Updated
Welcome to the first "Random Pick of The Week", where I will randomly select a ticker to chart based on comments posted below or sent via direct message.
Want a technical breakdown?
- Follow Me
- Smash Like
- Comment 1 Ticker
Todays's Pick:
AKBA / Akebia Therapeutics Inc.
Looking at the great scheme of things, we can see that AKBA has been in a steady downtrend for the last 5 years with only a few points of high demand. We've seen some massive leaps throughout the last 5 years, which is as expected knowing that we are trading biotech.
We look like we will sit in a wedge up toward the start of 2021, leaving us with sideways movement (-+8%) until. We look for a breakout and retest of this wedge if bulls have any hope of any run into the New Years'. If we break out, we have $3.95 set as a short-term target and $7 as our long-term. We must watch $2.75/$2.70 as our weekly support, if lost look to short toward $2.10/.20.
FYI: Ignore the green box, it decided to change angles last second.
DCJ | Happy Holidays
Want a technical breakdown?
- Follow Me
- Smash Like
- Comment 1 Ticker
Todays's Pick:
AKBA / Akebia Therapeutics Inc.Looking at the great scheme of things, we can see that AKBA has been in a steady downtrend for the last 5 years with only a few points of high demand. We've seen some massive leaps throughout the last 5 years, which is as expected knowing that we are trading biotech.
We look like we will sit in a wedge up toward the start of 2021, leaving us with sideways movement (-+8%) until. We look for a breakout and retest of this wedge if bulls have any hope of any run into the New Years'. If we break out, we have $3.95 set as a short-term target and $7 as our long-term. We must watch $2.75/$2.70 as our weekly support, if lost look to short toward $2.10/.20.
FYI: Ignore the green box, it decided to change angles last second.
DCJ | Happy Holidays
Note
Possible short inbound
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.